ZA200701713B - Virus-like particles comprising a fusion protein of the coat protein of AP205 and an antigenic polypeptide - Google Patents

Virus-like particles comprising a fusion protein of the coat protein of AP205 and an antigenic polypeptide

Info

Publication number
ZA200701713B
ZA200701713B ZA200701713A ZA200701713A ZA200701713B ZA 200701713 B ZA200701713 B ZA 200701713B ZA 200701713 A ZA200701713 A ZA 200701713A ZA 200701713 A ZA200701713 A ZA 200701713A ZA 200701713 B ZA200701713 B ZA 200701713B
Authority
ZA
South Africa
Prior art keywords
virus
particles
protein
antigenic polypeptide
fusion protein
Prior art date
Application number
ZA200701713A
Inventor
Martin F Bachmann
Tissot Alain
Jennings Gary
Renhofa Regina
Pumpens Paul
Cielens Indulis
Original Assignee
Cytos Biotechnology Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytos Biotechnology Ag filed Critical Cytos Biotechnology Ag
Publication of ZA200701713B publication Critical patent/ZA200701713B/en

Links

ZA200701713A 2004-09-21 2005-09-21 Virus-like particles comprising a fusion protein of the coat protein of AP205 and an antigenic polypeptide ZA200701713B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61130804P 2004-09-21 2004-09-21

Publications (1)

Publication Number Publication Date
ZA200701713B true ZA200701713B (en) 2008-07-30

Family

ID=38710384

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200701713A ZA200701713B (en) 2004-09-21 2005-09-21 Virus-like particles comprising a fusion protein of the coat protein of AP205 and an antigenic polypeptide

Country Status (2)

Country Link
CN (1) CN101023103A (en)
ZA (1) ZA200701713B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012525134A (en) * 2009-04-30 2012-10-22 サイトス バイオテクノロジー アーゲー Composition of influenza hemagglutinin and use thereof
CA2863695C (en) * 2012-02-16 2023-01-17 Vlp Therapeutics, Llc Virus like particle composition
KR20220162800A (en) * 2016-04-27 2022-12-08 벤치마크 애니멀 헬스 엘티디. Treatment of canine atopic dermatitis
CN106806890A (en) * 2016-12-28 2017-06-09 中国医学科学院医学生物学研究所 Recombinant human VEGF polypeptide tumor vaccine
US20210253671A1 (en) * 2018-06-07 2021-08-19 Prottech Inc. Pharmaceutical Composition Containing Fusion Protein and Use Thereof
CN111303303B (en) * 2020-03-31 2023-02-28 郑州市第六人民医院 Noro virus VP1 protein fused with exogenous peptide segment, preparation method and application
CN112500456B (en) * 2020-12-02 2022-10-28 深圳赫兹生命科学技术有限公司 Castration AP205 virus-like particle subunit vaccine
CN114634578B (en) * 2020-12-15 2024-04-02 榕森生物科技(北京)有限公司 Vaccine compositions against novel coronavirus infections
CN114632148A (en) * 2020-12-15 2022-06-17 榕森生物科技(北京)有限公司 Pathogen-like antigen vaccine and preparation method thereof
CN116789773B (en) * 2022-11-30 2024-02-20 华北制药金坦生物技术股份有限公司 Crude purification method for intracellular expression virus-like particles

Also Published As

Publication number Publication date
CN101023103A (en) 2007-08-22

Similar Documents

Publication Publication Date Title
ZA200701713B (en) Virus-like particles comprising a fusion protein of the coat protein of AP205 and an antigenic polypeptide
EP1802282A4 (en) Biocompatible protein particles, particle devices and methods thereof
EP1799255A4 (en) Recombinant human cytomegalovirus and vaccines comprising heterologous antigens
EP1635872A4 (en) Antibodies and fusion proteins that include engineered constant regions
HK1137439A1 (en) Fused pyrrolocarbazoles and methods for the preparation thereof
HK1116500A1 (en) Antibodies directed against amyloid-beta peptide and methods using same
IL169638A0 (en) Soluble fcyr fusion proteins and methods of use thereof
EP1482984A4 (en) Surrogate antibodies and methods of preparation and use thereof
IL179476A0 (en) Antibodies against human interleukin-13 and uses therefor
EP1575500A4 (en) Mesothelin vaccines and model systems
IL181083A0 (en) Synthetic hyperglycosylated protease-resistant polypeptide variants, oral formulations and methods of using the same
EP1663278A4 (en) Epo mimetic peptides and fusion proteins
EP1812030A4 (en) Anti-angiogenic peptides and methods of use thereof
EP1786451A4 (en) Anti-angiogenic peptides and methods of use thereof
IL178593A (en) Fcγriib-specific antibodies and methods of use thereof
GB0616745D0 (en) Methods and apparatus for determining the size and shape of particles
HK1082524A1 (en) Alphavirus particles and methods for preparation
IL210378A0 (en) Tumor associated antigen, peptides thereof, and use of same as ati-tumor vaccines
EP1660638A4 (en) Lipoparticles comprising proteins, methods of making, and using the same
EP1729795A4 (en) Albumin fusion proteins
HK1095152A1 (en) Platelet glycoprotein ib alpha variant fusion polypeptides and methods of use thereof
PL1930416T3 (en) Novel recombinant human hepatitis c virus-like particle and method for producing the same
EP1425036A4 (en) Virus coat protein/receptor chimeras and methods of use
GB0624182D0 (en) Isoelectric particles and uses thereof
IL183116A0 (en) Enteric coated bead comprising ixabepilone, and preparation thereof